Finance

Lists
Why is ALA up 2,04%?
Dive Deeper
ALA:ASX
Arovella Therapeutics Ltd
0,050 A$
+2,04%
(+0,0010) 1D
27 қаз., 16:00:00 GMT+11  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for ALA...
Open
0,05 A$
High
0,05 A$
Low
0,05 A$
Mkt. cap
59,23 млн
Avg. vol.
928,40 м.
Volume
476,18 м.
52-wk high
0,10 A$
52-wk low
0,05 A$
EPS
-0,01 A$
Shares outstanding
1,21 млрд
No. of employees
14
Open
0,05 A$
High
0,05 A$
Low
0,05 A$
Mkt. cap
59,23 млн
Avg. vol.
928,40 м.
Volume
476,18 м.
52-wk high
0,10 A$
52-wk low
0,05 A$
EPS
-0,01 A$
Shares outstanding
1,21 млрд
No. of employees
14
News stories
From web sources and news partners
About Arovella Therapeutics Ltd
CEOMichael Baker
Employees14
Founded1999
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in AUD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
1,60 млн
1,60 млн
144,61 м.
144,61 м.
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1,37 млн
1,37 млн
1,57 млн
1,57 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
721,91 м.
721,91 м.
670,81 м.
670,81 м.
Operating expense
2,75 млн
2,75 млн
2,86 млн
2,86 млн
Total operating expenses
2,75 млн
2,75 млн
2,86 млн
2,86 млн
Operating income
-1,15 млн
-1,15 млн
-2,71 млн
-2,71 млн
Other non operating income
-
-
-
-
EBT including unusual items
-939,35 м.
-939,35 м.
-2,52 млн
-2,52 млн
EBT excluding unusual items
-939,35 м.
-939,35 м.
-2,52 млн
-2,52 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
449,58 м.
449,58 м.
528,34 м.
528,34 м.
Net income
-939,35 м.
-939,35 м.
-2,52 млн
-2,52 млн
Net profit margin
-58,55%
-58,55%
-1 741,81%
-1 741,81%
Earnings per share
-
-
-
-
Interest and investment income
207,81 м.
207,81 м.
192,21 м.
192,21 м.
Interest expense
-
-
-
-
Net interest expenses
207,81 м.
207,81 м.
192,21 м.
192,21 м.
Depreciation and amortization charges
29,58 мың
29,58 мың
29,28 мың
29,28 мың
EBITDA
-1,12 млн
-1,12 млн
-2,68 млн
-2,68 млн
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google қолданбалары